Men's Health
What Causes Low Libido in Men Who Are Overweight?
Carrying excess body weight does more than affect how you feel in the mirror — it triggers a cascade of hormonal, metabolic, and inflammatory changes that directly suppress male sex drive. Studies show that obese men are 2–3 times more likely to report low libido than men at a healthy weight. Understanding the mechanisms is the first step toward fixing them.

What Causes Low Libido in Men Who Are Overweight?
Yes, excess body fat directly suppresses male libido through at least four distinct mechanisms: aromatization of testosterone to estrogen in adipose tissue, elevated insulin and leptin resistance, chronic low-grade inflammation, and disrupted sleep architecture from sleep apnea. The effect compounds with BMI — the heavier, the lower the testosterone. Men who are only mildly overweight may notice subtle changes; men with significant obesity often have clinically hypogonadal testosterone levels.
How Excess Body Fat Suppresses Testosterone
The most direct pathway is aromatization. Adipose (fat) tissue expresses the enzyme aromatase, which converts testosterone into estradiol. The more fat you carry — particularly visceral and subcutaneous abdominal fat — the more aromatase activity you have, and the faster circulating testosterone is converted into estrogen.
A landmark analysis published in the Journal of Clinical Endocrinology & Metabolism found that for every 4–5 kg/m² increase in BMI, total testosterone drops by approximately 2 nmol/L, independent of age (Tajar et al., 2010; PMID: 20610608). That is a clinically meaningful drop — the kind that moves a man from the mid-normal range into the low-normal or frankly deficient range.
Meanwhile, rising estradiol signals the hypothalamus to suppress GnRH pulses, which in turn reduces LH secretion from the pituitary. Less LH means less stimulus for the testes to produce testosterone. The result is a self-reinforcing cycle: fat → more aromatase → more estrogen → suppressed GnRH/LH → less testosterone → more fat deposition.
Sex hormone-binding globulin (SHBG) also falls with obesity and hyperinsulinemia. SHBG carries testosterone in the blood; when SHBG is low, free testosterone looks adequate on paper — but the accompanying metabolic dysfunction and high estradiol still suppress libido centrally. Checking free testosterone and estradiol alongside total testosterone gives a much clearer picture than a single total-T draw.
The Insulin Resistance and Leptin Connection
Obesity is tightly linked to insulin resistance, which suppresses SHBG and alters hypothalamic signaling. But leptin — the satiety hormone produced by fat cells — plays an underappreciated role in libido specifically.
At normal levels, leptin supports gonadotropin-releasing hormone (GnRH) pulsatility. At the chronically elevated levels seen in obese men (leptin resistance), the opposite occurs: hypothalamic GnRH pulses become blunted, reducing the downstream testosterone signal (Mah & Wittert, 2010; PMID: 20349526). Men with metabolic syndrome — a cluster that includes central obesity, elevated fasting glucose, high triglycerides, and low HDL — have been shown to have testosterone levels 30% lower on average than metabolically healthy men of the same age.
Hyperinsulinemia also suppresses SHBG synthesis in the liver. Lower SHBG means more free testosterone initially, but insulin-driven suppression of testicular function and the aromatization burden together still net a lower androgenic environment. For men dealing with both low libido and poor blood sugar regulation, addressing insulin sensitivity is not optional — it is central to any hormone-recovery strategy.
If you want a broader overview of how hormonal and nutritional factors interplay in male sex drive, the article on low libido: the hormonal, nutritional, and stress drivers for men and women is worth reading alongside this one.
Inflammation, Cortisol, and the Stress Axis
Visceral fat is metabolically active. It secretes pro-inflammatory cytokines — IL-6, TNF-α, and CRP — at levels proportional to the amount of visceral adiposity. Chronic low-grade inflammation interferes with the HPG (hypothalamic-pituitary-gonadal) axis at multiple points and directly impairs Leydig cell function in the testes.
A 2013 meta-analysis in Obesity Reviews confirmed that elevated CRP and IL-6 are independently associated with lower testosterone in men, even after adjusting for BMI (Maggio et al.; PMID: 23121117). This means inflammation is not just a marker — it is mechanistically suppressing hormone production.
Excess visceral fat also elevates cortisol output through overactivation of the HPA (hypothalamic-pituitary-adrenal) axis. Cortisol and testosterone are antagonistic: cortisol suppresses GnRH and LH, and high cortisol chronically redirects steroid precursors away from testosterone synthesis. Men under metabolic stress from obesity often sit in a state of subclinical hypercortisolism that compounds every other mechanism described here.
Sleep apnea — extraordinarily common in overweight men — makes this worse. Repeated hypoxic episodes during sleep acutely suppress testosterone. Men with moderate-to-severe sleep apnea have testosterone levels approximately 25% lower than men without it (Luboshitzky et al., 2002; PMID: 12059986), and the depressed testosterone is not primarily explained by obesity alone — the hypoxia and sleep fragmentation are independently responsible.
Selenium for Men: A Micronutrient Often Missed
When clinicians think about libido and male hormones, they focus on zinc — rightfully so. But selenium is increasingly recognized as critical for male reproductive function and thyroid conversion, both of which affect libido.
Selenium is a cofactor for iodothyronine deiodinases, the enzymes that convert inactive thyroid hormone (T4) to active T3. Thyroid hormone directly regulates Leydig cell sensitivity to LH. Men who are overweight frequently have subclinical hypothyroidism or sluggish T4-to-T3 conversion, and low selenium status makes this worse. A 2016 systematic review in Thyroid found that selenium supplementation (200 mcg/day as selenomethionine) significantly improved thyroid hormone ratios in populations with marginal selenium intake (Ventura et al., 2017; PMID: 27702392).
Selenium is also an antioxidant cofactor (via glutathione peroxidase) that protects Leydig cells from oxidative stress — the same oxidative burden elevated by obesity-related inflammation. Selenium-deficient men show impaired sperm motility and lower testosterone in observational data, though intervention trials specifically targeting libido are limited.
For men with overweight-associated low libido who also have borderline thyroid function or elevated inflammatory markers, selenium at 100–200 mcg/day (preferably selenomethionine or selenium-enriched yeast for bioavailability) is worth discussing with your provider.
Ferrous Bisglycinate for Men: Why Iron Status Matters More Than You Think
Iron deficiency is typically discussed in the context of women, but overweight men can develop functional iron deficiency through a separate mechanism: chronic inflammation elevates hepcidin, the master regulator of iron absorption. Hepcidin blocks ferroportin channels in the gut, reducing dietary iron uptake even when intake is adequate.
The result is a man who eats enough iron but absorbs relatively little — leading to low ferritin, reduced hemoglobin, and the familiar fatigue-and-low-drive picture that overlaps significantly with hypogonadism. The two conditions can easily be confused without lab work.
When iron repletion is indicated in men, ferrous bisglycinate is the preferred form. Compared to ferrous sulfate, bisglycinate is absorbed at 2–4 times the rate, causes substantially less gastrointestinal discomfort, and is better tolerated at therapeutic doses (Szarfarc et al., 2001; PMID: 11688081). Men who supplement iron without confirmed deficiency run real risks — iron overload is associated with oxidative stress, metabolic dysfunction, and cardiovascular risk — so this is one area where a ferritin test before supplementing is non-negotiable.
If you're curious about how ferritin affects energy and drive more broadly, the piece on what causes low ferritin in women covers the biomarker mechanics in detail, much of which applies to men with inflammation-driven depletion.
The Biomarker Panel Every Overweight Man with Low Libido Should Run
Libido symptoms are nonspecific. Without labs, you're guessing. Here is the core panel that maps to the mechanisms above:
| Biomarker | What It Tells You | Target Range (men) |
|---|---|---|
| Total Testosterone | Overall androgen status | 400–700 ng/dL (optimal) |
| Free Testosterone | Active androgen fraction | Top tertile for age |
| Estradiol (E2) | Aromatization burden | 20–30 pg/mL |
| SHBG | Binding protein affecting free T | 20–55 nmol/L |
| LH / FSH | Pituitary output signal | Mid-normal range |
| Fasting Insulin | Metabolic driver of SHBG suppression | <10 μIU/mL |
| hsCRP | Inflammatory load | <1.0 mg/L |
| Ferritin | Iron stores / hepcidin effect | 70–150 ng/mL |
| TSH + Free T3 | Thyroid-Leydig cell axis | TSH 1–2.5 mIU/L |
| Selenium (if available) | Deiodinase + antioxidant status | 120–150 μg/L |
| Vitamin D (25-OH) | Steroidogenesis cofactor | 50–80 ng/mL |
This panel gives you the mechanistic picture, not just a testosterone number. Many men discover their estradiol is high-normal, their ferritin is marginal, and their hsCRP is elevated — a pattern that explains every symptom even when total testosterone is technically "in range."
For related hormonal drivers in different metabolic contexts, the discussion of what causes low libido in PCOS illustrates how insulin resistance suppresses libido through shared HPG-axis mechanisms — useful for understanding the broader biology even in a male context.
What This Means for Your Formula
Ones uses blood work, wearable data, and health history to build a personalized capsule formula calibrated to the specific deficiencies and imbalances driving your symptoms. For overweight men with low libido, the formulation logic typically targets three interrelated problems:
Ashwagandha (KSM-66, 600 mg): A 2019 randomized controlled trial in men with low testosterone found that KSM-66 ashwagandha increased testosterone by 14.7% and improved sexual health scores versus placebo, attributed to cortisol reduction and direct support of the HPG axis (Chauhan et al., 2019; PMID: 31728244). For men whose low libido is partly driven by HPA overactivation and cortisol-mediated testosterone suppression — common in overweight men — this is a well-matched intervention. See also: does ashwagandha help with low libido.
Selenium (as selenomethionine, 200 mcg): Ones includes selenomethionine at the dose used in thyroid and antioxidant trials, supporting T4-to-T3 conversion and protecting Leydig cells from oxidative stress — both relevant in the inflammatory, metabolic milieu of overweight men.
Vitamin D3 + K2 (MK-7): Vitamin D receptors are expressed on Leydig cells, and D3 supplementation in deficient men has been associated with significant increases in testosterone (Pilz et al., 2011; PMID: 21154195). Given that overweight men absorb and activate vitamin D less efficiently due to fat sequestration, this is frequently a gap in the formula for this population.
Ones does not apply a generic men's formula. The AI reviews your specific labs and wearable signals — including sleep quality, which tracks apnea risk — to determine which of these ingredients are relevant for your case and at what dose.
Key Takeaways
- Excess body fat increases aromatase activity, converting testosterone to estradiol and triggering a self-reinforcing cycle of hormonal suppression via the GnRH/LH axis.
- Insulin resistance and leptin resistance — common companions of obesity — further blunt HPG axis signaling and lower SHBG, compounding the androgenic deficit.
- Chronic low-grade inflammation (elevated IL-6, TNF-α, hsCRP) directly impairs Leydig cell function and suppresses testosterone production independently of BMI.
- Sleep apnea, prevalent in overweight men, acutely suppresses testosterone through hypoxia and sleep fragmentation — addressing sleep quality is not optional in this population.
- Micronutrient gaps in selenium, vitamin D, and iron (ferrous bisglycinate when repletion is needed) are frequently overlooked contributors to low libido in metabolically stressed men.
- A targeted biomarker panel — including free testosterone, estradiol, SHBG, fasting insulin, ferritin, hsCRP, and thyroid markers — is essential to understand which mechanisms are active before choosing a supplement protocol.